4//SEC Filing
Burgess Michael F. 4
Accession 0001104659-22-081241
CIK 0001773427other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 6:02 PM ET
Size
4.8 KB
Accession
0001104659-22-081241
Insider Transaction Report
Form 4
Burgess Michael F.
Head of Research & Development
Transactions
- Tax Payment
Common Stock
2022-07-18$28.47/sh−3,103$88,342→ 49,584 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock awards and does not represent a sale by the Reporting Person.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001801745
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 6:02 PM ET
- Size
- 4.8 KB